glp-1 incretin is released from the small intestine after meal ingestion and Incretin hormones and obesity -

Once-monthly maridebart cafraglutide for the treatment of obesity - A phase 2 trial

Additionally, intensive support is typically required to ensure that members remain compliant with behavior changes for the long-term

Back Marks, LV (2010) Sexual Chemistry: A History of the Contraceptive Pill

Applying the patch for longer periods can lead to side effects such as: Erythema (redness) Pruritus (itching) Contact dermatitis Skin inflammation Burning sensation GLP-1 transdermal patches may also cause hypersensitivity reactions and skin sensitization after repeated exposure

GLP-1 Medications and NAION: What Patients Should Know About Sudden Vision Loss David B

Heres what the latest science says about GLP-1 drugs and weight loss